In March 2025, the company announced new designs for any direct-to-customer giving of its Wegovy weight loss drug. The company recognized a different pharmacy, known as NovoCare, which might cost customers $499 each month for entry to the drug, below 50 % the cost of the drug by means of other pharmaceutical distribution networks.[fifty three]At th